BTCY Biotricity, Inc Quick Ratio

The market trend for Biotricity, Inc. (BTCY) visualized in monetary terms demonstrates the dynamics of a company with a metric of 0.11. The business relies on an autonomous development cycle and drug discovery, serving as a defensive asset. Demand for remote cardiac monitoring remains independent of economic phases and seasonality. Cloud data transmission minimizes patient travel costs, ensuring the accuracy of examinations.

Biotricity, Inc. (BTCY) is transitioning to mass B2B sales of SaaS solutions, which necessitates strict working capital management. This assessment of short-term solvency, excluding inventories, measures the company's ability to meet its obligations using only cash and accounts receivable. The positive trend on this chart confirms the efficiency of subscription payment collection and the minimization of cash flow gaps. Steady growth of this indicator strengthens the fundamental value of the business during its scaling phase.